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Introduction
============

Prone positioning (PP) improves arterial oxygenation in 50 to 75% of patients presenting with acute respiratory distress syndrome (ARDS) \[[@B1]\]. Although this postural treatment is currently considered simple and safe \[[@B1]\], the restriction of abdominal movements during PP is associated with an increase in intra-abdominal pressure (IAP) \[[@B2]-[@B5]\] with potential adverse effects on hemodynamic status and splanchnic perfusion \[[@B6]-[@B8]\]. Several studies have evaluated the clinical implications of this side effect of PP \[[@B4],[@B5],[@B9]\]. They reported significant but limited increases in IAP without impairment of cardiopulmonary, renal or hepatosplanchnic functions during short periods of PP. However, all patients included in these studies were placed on air-cushioned beds, which might have reduced the restriction of abdominal movement during PP \[[@B4],[@B5],[@B9]\] compared with a conventional foam mattress. Indeed, the air-cushioned mattress reduced interface pressure to a greater extent than the foam mattress \[[@B10],[@B11]\]. Moreover, the addition of pillows under the thorax and the pelvis did not produce a decrease in IAP during the PP procedure with a foam mattress \[[@B12]\]. Because no direct comparison has been made between different supports, the respective influences of the type of support and the posture itself on IAP and its related potential adverse effects remain unclear. Therefore, in the perspective of standardization, the question of the interest of a special device before the institution of PP should be clarified \[[@B1]\].

The aim of the present study was to investigate whether the evolution of IAP, liver function assessed by the plasma disappearance rate of indocyanine green (PDR~ICG~) \[[@B5]\] and extra-vascular lung water is related to the type of support during PP. We therefore prospectively compared, in a population of medical-ARDS patients, the effects of an air-cushioned mattress and a conventional foam mattress during PP.

Methods
=======

Patients
--------

Twenty consecutive patients with ARDS were included and turned prone in the medical intensive care unit of Sainte Marguerite University Hospital in Marseille, France. Patients were prospectively included in this study after obtaining written informed consent from the next of kin. The study design was approved by the Comité Consultatif de Protection des Personnes dans la Recherche Biomédicale of Marseille. ARDS was defined in accordance with the recommendations of the American--European Consensus Conference \[[@B13]\]. Patients with unstable cardiovascular function, cerebral injury or unstable spinal fractures, patients subjected to major abdominal surgery and patients with a history of neuromuscular disease were excluded.

Sedation, catheters and ventilation
-----------------------------------

All patients were sedated and paralyzed by the continuous infusion of sufentanil, midazolam and cisatracurium throughout the study period and were ventilated with conventional volume-controlled mechanical ventilation (7200 series or 840, Mallinckrodt Puritan Bennett, Carlsbad, CA, USA).

Respiratory and hemodynamic status was stable for 12 hours before inclusion. When patient received vasoactive drugs, the rate of infusion was kept stable throughout the study. On inclusion into the study, the mean tidal volume was 6.9 ± 1.9 ml/kg, the mean respiratory rate was 20 ± 4 cycles/min (the respiratory rate was adjusted to maintain a constant minute ventilation throughout the study period) and the positive end-expiratory pressure was 11.3 ± 2.0 cmH~2~O. The selection of the appropriate PEEP level was performed by increasing PEEP in steps of 2 cmH~2~O. A blood gas analysis was performed after a 30 min period of stabilization of blood oxygen saturation. Finally, the lower level of PEEP giving the greater improvement of oxygenation was chosen. The levels of PEEP, the tidal volume and a fraction of inspired oxygen (FiO~2~) of 0.8 were maintained constant throughout the study period.

A pulmonary artery catheter (Baxter Healthcare Corporation, Irvine, CA, USA) was placed in all patients. It was inserted percutaneously through the right jugular or left subclavian vein and positioned with the distal port in the pulmonary artery and the proximal port in the right atrium. For measurements of the PDR~ICG~and extravascular lung water (EVLW), a 5F catheter was placed into the left femoral artery, together with a thermistor-tipped fiber-optic catheter (Pulsiocath, 4F, FT, PV-2024-L; Pulsion Medical System, Munich, Germany) which was advanced into the descending aorta.

Support surfaces
----------------

The control surface was a three-piece molded foam mattress (APLOT^®^; Asklé, Nîmes, France). The specialist air mattress was a dynamic alternating cells design, with automatic adjustment for patient weight (ProNimbus^®^; Huntleigh Healthcare, Luton, UK).

Measurements
------------

### Hemodynamic parameters

Routine invasive hemodynamic monitoring included arterial and pulmonary artery thermodilution catheters. Systemic and pulmonary arterial pressures, pulmonary artery occlusion pressure and right atrial pressure were measured at end-expiration. The midaxillary line was taken as the zero reference point in the supine and prone positions. Cardiac index, venous admixture and pulmonary vascular resistance were calculated from conventional formulas.

### Blood gas analysis

Systemic and pulmonary arterial blood samples were withdrawn simultaneously within 3 min after the measurement of cardiac output. Arterial pH, arterial oxygen tension (PaO~2~) and arterial CO~2~tension were measured with a blood gas analyzer (278-blood gas system; Ciba Corning, Medfield, MA, USA). Arterial and mixed venous oxygen saturation (SaO~2~and SvO~2~, respectively) were measured with a calibrated hemoximeter (270-CO-oxymeter; Ciba Corning).

### Respiratory parameters

The respiratory parameters measured were compliance of the respiratory system, exhaled tidal volume, peak inspiratory pressure, mean inspiratory pressure, and respiratory rate. Quasi-static compliance of the total respiratory system was obtained by dividing the tidal volume by the difference between plateau pressure and the total PEEP according to the method described by Gattinoni and colleagues \[[@B14]\].

### Thoracic volumes, EVLW and hepatosplanchnic perfusion measurements

The transpulmonary indicator dilution technique was used to determine the intrathoracic blood volume, the EVLW and the PDR~ICG~\[[@B15]\]. PDR~ICG~is derived from the half-life of indocyanine green and reflects the percentage of the initial plasma dye level eliminated by the liver \[[@B16]\]. A thermistor-tipped fiber-optic catheter placed in the descending aorta detected the dye and temperature dilution curves. The EVLW and the PDR~ICG~were automatically calculated by a computer (Pulsion Cold Z-021; Pulsion Medical System) from the average of three measurements \[[@B16]\].

### Measurement of IAP

IAP was measured with a transurethral bladder catheter \[[@B17]\]. Normal saline (100 ml) was infused through the urinary catheter into the bladder. The catheter was then clamped and the IAP was recorded by a pressure transducer as mean pressure at end-expiration. Zero was set at the level of the pubis in both positions.

Protocol
--------

Baseline measurements were performed in the supine position after 1 hour of steady-state conventional mechanical ventilation. Then the following two periods of PP were randomized: 6 hours of PP on the moulded foam mattress, and 6 hours of PP on the air-cushioned mattress. A period of 18 h in the supine position separated the two periods in the prone position. Each patient was his or her own control. Measurements were achieved in the supine position, after 1 and 6 hours of PP.

Change in position was performed manually by three nurses and two staff members. In the prone position, the arms were laid parallel to the body. Care was taken to avoid eye damage and any non-physiological movements of the limbs during posture changes. Whatever type of support was used, no pillow was used to support regions such as the chest or pelvis.

Measurements were performed before, after 1 hour and after 6 hours of each period of PP.

Statistical analysis
--------------------

Statistical calculation was performed with the Sigma Stat 3.0 package (SPSS Inc., Chicago, IL, USA). Distribution was checked. Data were expressed as mean ± SD if the distribution was normal and as medians and interquartile range if the distribution was not normal. Significant differences were analyzed by general factorial analysis of variance (ANOVA) with a prior logarithmic transformation when required (non-parametric distribution). For intra-group changes, Tukey\'s test for multiple comparisons was applied to compare the variations between supports and different times of the study. For serum transaminases and creatinine, a Mann--Whitney *U*-test was used to compare the values before and after the protocol. When a correlation was calculated, Pearson\'s coefficient of correlation was used. When distribution was not normal, Spearman\'s rank correlation was used.

*P*\< 0.05 was considered significant.

Results
=======

Characteristics of the population are listed in Table [1](#T1){ref-type="table"}. On admission, the mean Simplified Acute Physiologic Score II (SAPS II) score was 52 ± 12 and the severity of ARDS was assessed by a lung injury score of more than 2.5 in all patients (3.1 ± 0.3). The mortality rate for the 20 patients (15 men, 5 women; age 53 ± 12) was 25%. Among the patients enrolled in the study, six patients received norepinephrine (noradrenaline) (dose 0.3 ± 0.2 μg/kg per min) and one patient received epinephrine (adrenaline) (0.4 μg/kg per min) on inclusion. No modification of the infusion rate of norepinephrine and epinephrine and no fluid expansion were undertaken during the study period.

Effects of prone position and support on IAP, hepatosplanchnic function and EVLW
--------------------------------------------------------------------------------

A logarithmic transformation of the data led to normally distributed values of IAP and PDR~ICG~. We therefore performed a two-way ANOVA that showed an increase in IAP after 1 and 6 hours of PP on a foam mattress in comparison with baseline values (*P*\< 0.01 by Tukey\'s test; Fig. [1](#F1){ref-type="fig"}) whereas it remained unchanged when patients were positioned on a specialist air mattress. IAP was higher on a foam mattress after 6 hours of PP in comparison with a specialist air mattress (*P*\< 0.05 by Tukey\'s test; Fig. [1](#F1){ref-type="fig"}). PDR~ICG~decreased after 1 and 6 hours of PP on a foam mattress in comparison with baseline values (*P*\< 0.05 by Tukey\'s test, Table [2](#T2){ref-type="table"} and Fig. [2](#F2){ref-type="fig"}) whereas it remained unchanged when patients were positioned on a specialist air mattress.

There was no correlation between changes in IAP and PDR~ICG~. Furthermore, the analysis of hepatic and renal variables did not show any statistical variation after the PP procedure period (Table [3](#T3){ref-type="table"}).

There was no modification in EVLW and intrathoracic blood volume related to posture or support changes (Table [2](#T2){ref-type="table"}).

Effects of prone position and support on gas exchange (Table [2](#T2){ref-type="table"})
----------------------------------------------------------------------------------------

PP induced an increase in the PaO~2~/FiO~2~ratio (*P*\< 0.001 by ANOVA) regardless of the type of support. There was no correlation between evolution in PaO~2~and changes in IAP. PP reduced the true pulmonary shunt (*P*\< 0.05 by ANOVA) without any influence of the kind of support.

Effects of prone position and support on hemodynamic and respiratory parameters (Table [2](#T2){ref-type="table"})
------------------------------------------------------------------------------------------------------------------

ANOVA showed that CVP, mean pulmonary arterial pressure and pulmonary artery occlusion pressure increased significantly in PP (*P*\< 0.001) without any influence of the kind of support. Although PP induced a significant reduction in the static compliance of the total respiratory system (*P*= 0.007 by ANOVA), these modifications were not influenced by the kind of support. Other hemodynamic or respiratory parameters were not affected by prone position or type of support.

Discussion
==========

The results of this study indicate that the use of an air-cushioned mattress for the PP procedure limited the increase of IAP and prevented a decrease in PDR~ICG~related to PP. Nevertheless, these modifications were not associated with differences between supports for EVLW, oxygenation or cardiovascular parameters.

Even if the routine use of PP did not improve the survival of patients with ARDS in a recent multicenter randomized trial \[[@B18]\], it could be considered useful in the more hypoxemic patients. The improvement in oxygenation produced by PP is often related to an increase in aerated lung tissue with a decrease in venous admixture and a decrease in thoraco-abdominal compliance \[[@B19]\]. On the basis of these considerations, one can presume that the more the thoraco-abdominal wall is restricted during PP, the greater the gain in arterial oxygenation that should be obtained \[[@B4]\]. Nevertheless, in different settings, turning patients prone has been reported to induce an increase in IAP with potential side effects on cardiopulmonary, renal and hepatosplanchnic function \[[@B7],[@B8]\]. The impaired hepatosplanchnic perfusion could lead to the development of multiple system organ failure \[[@B7],[@B20],[@B21]\], increasing the mortality rate of patients with ARDS \[[@B22],[@B23]\].

Several studies were therefore designed to investigate the effects of PP on IAP modifications and clinical consequences \[[@B4],[@B5],[@B9]\]. The cumulative results of these studies indicate that, despite a small increase in IAP, PP improves arterial oxygenation without affecting cardiopulmonary, renal or hepatosplanchnic function. Nevertheless, the constant use of air-cushioned beds during PP in these studies could have contributed to limiting the effects of PP on IAP \[[@B5]\]. Indeed, this specialist air mattress presents a dynamic alternating-cells design with automatic adjustment for patient weight and a redistribution in pressure from the heavy parts (abdomen) to other areas. This support has been extensively reported as providing the lowest interface pressure in comparison with other supports, including foam mattresses \[[@B10],[@B11]\]. Conversely, the use of a foam rubber mattress has recently been associated with an increase in IAP during PP without further reduction when pillows were added under the thorax and the pelvis \[[@B12]\].

Similarly, in our study, the use of foam rubber mattresses during PP induced a significant increase in IAP with a concomitant reduction in PDR~ICG~, whereas air-cushion mattresses did not do so. Although these findings seem to indicate a superiority of the air-cushion support in terms of abdomen release, the clinical consequences of such modifications should be interpreted with regard to their duration. Indeed, despite an increase in IAP reaching 15 mmHg after 6 hours of PP on a foam mattress, the differences in liver function evaluated by PDR~ICG~were limited during the PP procedure and did not induce significant modifications in hepatic biological variables during the period after PP. Conversely, although previous results have shown that a higher level must be reached to induce clinical modifications \[[@B24],[@B25]\], a recent multicenter epidemiological study has reported the detrimental influence of a prolonged increase in IAP even for such moderate levels as 12 mmHg \[[@B26]\].

Another consequence of an increase in IAP during PP could be the modification of EVLW. Indeed, a decrease in EVLW has been proposed as an alternative mechanism that might account for the benefit related to PP \[[@B27]\]. Furthermore, an increase in IAP has recently been reported to worsen pulmonary edema in a lung injury induced by oleic acid \[[@B28]\]. Despite a PP-related increase in IAP with the foam mattress, our results did not demonstrate a significant modification in EVLW. The basal levels and the limited differences in IAP between the two supports probably explained the lack of influence of support on pulmonary edema assessed by EVLW in our study. An alternative, although not mutually exclusive, explanation for the observed evolution in EVLW could result from the underestimation of edema by this technique, because several areas of the lung are underperfused during ARDS \[[@B29]\].

Because the first objective of PP is still the improvement of ARDS-related hypoxemia, the potential influence of the support on oxygenation evolution represents another subject of concern \[[@B19],[@B30],[@B31]\]. Our results confirm previous data on PP-related oxygenation improvement but do not report any difference between the supports. The fact that the type of support does not appreciably influence the effects of PP on gas exchange has been deduced from previously published studies. Although Pelosi and colleagues reported an improvement in PaO~2~that was correlated with a decrease in thoraco-abdominal compliance \[[@B19]\], these results were interpreted as being principally related to the modification of the chest-wall component of the thoraco-abdominal compliance during PP, without significant intervention of the abdominal part. Furthermore, Colmenero-Ruiz and colleagues, in an experimental study, showed that abdomen release in PP does not induce significant modification in oxygenation \[[@B31]\].

However, it should be noted that all patients included in the present study presented a medical etiology for their ARDS with an IAP in the supine position that was expected to be lower than in a surgical patient population. Consequently, our results must be interpreted with regard to our selected population because the effects of different support during PP could be different in patients with increased IAP (especially in surgical patients). Indeed, Gattinoni and colleagues \[[@B32]\] reported an IAP ranging from 6 mmHg in patients with ARDS of pulmonary cause to 16 mmHg in patients presenting with ARDS of extrapulmonary cause. The basal level of IAP and the magnitude of changes during PP for surgical patients could induce more relevant results than in our study and imply the need for further investigation in this population.

Our results suggest that the limited modifications in cardiovascular, renal or hepatosplanchnic function observed during PP are probably not related to the type of support but most probably to the relative harmlessness of this postural technique because patients do not present abdominal hypertension before prone positioning.

Conclusion
==========

Consequently, the use of an air-cushion mattress for PP seems to be unnecessary in a standardized protocol in medical patients. However, the use of an air-cushion mattress is still of particular interest in reducing the incidence of pressure ulcers when prolonged periods of PP are needed and in facilitating the PP procedure for tracheostomized patients. Nevertheless, because the duration of PP period was limited to 6 hours in our protocol, a specific comparison between the two supports regarding skin lesions was not made in the present study and will require further evaluation.

Key messages
============

• In a population of medical-ARDS patients, the evolution of IAP and liver function during prone positioning is partly related to the type of support.

• The use of an air-cushion mattress do not influence the oxygenation and EVLW evolution during prone positioning.
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![Effects of both supports on intra-abdominal pressure (IAP). The different durations of study are reported along the *X*-axis: SP, PP 1 H and PP 6 H represent baseline in supine position, prone position at 1 hour and prone position at 6 hours, respectively. Pale gray boxes, foam mattress; dark gray boxes, air-cushion mattress. Each box plot represents the median, the 25th and 75th centiles, and the largest and smallest values that are not outliers. Outliers are represented as filled circles. *P*\< 0.01 and *P*\< 0.05 by Tukey\'s post-hoc test.](cc3513-1){#F1}

![Effects of both supports on the plasma disappearance rate (PDR) of indocyanine green. The different durations of study are reported along the *x*-axis: SP, PP 1 H and PP 6 H represent baseline in supine position, prone position at 1 hour and prone position at 6 hours, respectively. Pale gray box, foam mattress; dark gray box, air-cushion mattress. Each box plot represents the median, the 25th and 75th centiles, and the largest and smallest values that are not outliers. Outliers are represented as filled circles. *P*\< 0.05 by Tukey\'s post-hoc test](cc3513-2){#F2}

###### 

Characteristics of the population

  Patient no.   Age (years)   Sex   BMI   LIS   SAPS II   ARDS duration (days)   Causes of ARDS                 Outcome
  ------------- ------------- ----- ----- ----- --------- ---------------------- ------------------------------ ---------
  1             51            M     42    3.0   39        4                      Bacterial pneumonia            Alive
  2             39            M     27    3.0   60        1                      Aspiration pneumonia           Alive
  3             65            M     33    3.3   46        1                      Cytomegalovirus pneumonia      Alive
  4             64            M     28    2.7   71        2                      Bacterial pneumonia            Alive
  5             50            F     23    2.7   49        7                      Septic shock                   Died
  6             44            M     24    3.3   45        1                      Bacterial pneumonia            Alive
  7             71            M     26    3.6   51        7                      Bacterial pneumonia            Died
  8             37            M     34    3.2   30        3                      Lung contusion                 Alive
  9             45            M     25    3.3   62        1                      Bacterial pneumonia            Died
  10            37            M     25    3.2   74        6                      Community-acquired pneumonia   Alive
  11            52            F     37    2.7   52        4                      Aspiration pneumonia           Alive
  12            49            M     25    2.7   40        2                      Bacterial pneumonia            Alive
  13            70            M     28    3.2   57        4                      Bacterial pneumonia            Alive
  14            48            F     31    3.5   72        1                      Aspiration pneumonia           Alive
  15            60            F     27    3.2   58        2                      Septic shock                   Alive
  16            48            M     29    3.7   44        7                      Bacterial pneumonia            Alive
  17            73            M     38    3.3   62        4                      Aspiration pneumonia           Died
  18            56            M     25    2.7   56        3                      Community-acquired pneumonia   Alive
  19            34            F     28    2.5   32        3                      Bacterial pneumonia            Alive
  20            65            M     23    3.3   48        2                      Aspiration pneumonia           Died

ARDS duration, duration of acute respiratory distress syndrome before inclusion BMI, body mass index; LIS, lung severity score; SAPS II, Simplified Acute Physiologic Score II

###### 

Respiratory and hemodynamic parameters

  Parameter                Foam mattress   Specialist mattress   ANOVA                                                                        
  ------------------------ --------------- --------------------- -------------- ------------ -------------- -------------- ------------- ---- ----
  PaO~2~/FiO~2~            142 ± 63        178 ± 73              217 ± 69\*     143 ± 44     206 ± 127\*    243 ± 80\*     *P*\< 0.001   NS   NS
  PaO~2~(mmHg)             45 ± 9          44 ± 9                44 ± 1 0       45 ± 6       46 ± 10        44 ± 11        NS            NS   NS
  Q~VA~/Q~T~(%)            37 ± 8          37 ± 9                35 ± 9\*       37 ± 8       36 ± 10        34 ± 10\*      *P*\< 0.05    NS   NS
  Paw (cmH~2~O)            18 ± 3.5        18.2 ± 3              18 ± 3         19 ± 4       19 ± 4         18.4 ± 4       NS            NS   NS
  Cst (ml/cmH~2~O)         38.4 ± 10       35.4 ± 8\*            37.1 ± 9       38.6 ± 11    35.8 ± 8\*     37 ± 8         *P*= 0.007    NS   NS
  MPAP (mmHg)              27 ± 4          32 ± 7                30 ± 6         27 ± 4       31 ± 7         32 ± 7         NS            NS   NS
  PAOP (mmHg)              12.2 ± 3.0      16.7 ± 4.0\*          15.7 ± 4.0\*   12.5 ± 5.0   15.8 ± 4.0\*   15.9 ± 4.0\*   *P*= 0.02     NS   NS
  CVP (mmHg)               9.6 ± 4.1       13.7 ± 4              13.1 ± 5       9.4 ± 6      13 ± 5.0       13.5 ± 5.0     *P*= 0.02     NS   NS
  CI (l/min per m^2^)      4.3 ± 1.1       4.3 ± 1.2             4 ± 0.9        4.5 ± 0.9    4.1 ± 1.3      4.1 ± 0.9      NS            NS   NS
  EVLWI (ml/kg per m^2^)   11.2 ± 6.0      11.1 ± 6.2            10 ± 6.5       11.5 ± 7.3   9.5 ± 6.2      10.6 ± 6.0     NS            NS   NS
  ITBV (ml)                1140 ± 475      1100 ± 535            942 ± 330      1165 ± 435   972 ± 205      985 ± 225      NS            NS   NS

Values are expressed as mean ± SD.

ANOVA, analysis of variance; CI, cardiac index; Cst, respiratory static compliance; CVP, central venous pressure; EVLWI, indexed extravascular lung water; FiO2, fraction of inspired oxygen; ITBV, intrathoracic blood volume; MPAP, mean pulmonary arterial pressure; PaCO2, arterial CO2 tension; PaO2, arterial oxygen tension; PAOP, pulmonary artery occlusion pressure; Paw, plateau airway pressure; PP, prone positioning; QVA/QT, venous admixture. \*P \< 0.05 compared with baseline by Tukey\'s post-hoc test.

###### 

Hepatic and renal variables

  Variable              On inclusion     End of protocol
  --------------------- ---------------- -----------------
  Bilirubin (μmol/l)    14 ± 9           21 ± 17
  ASAT (IU/l)           30 \[20--40\]    27 \[18--52\]
  ALAT (IU/l)           22 \[15--34\]    24 \[17--49\]
  Creatinine (μmol/l)   72 \[58--100\]   75 \[58--91\]
  Prothrombin (%)       63 ± 9           61 ± 8

ASAT, aspartate aminotransferase; ALAT, alanine aminotransferase. For bilirubin and prothrombin, data are expressed as mean ± SD. For transaminases and creatinine, data are expressed as median \[interquartile range\].
